ARCHIVES

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

President, First Lady Visit Clinical Center, Hail ‘Compassion’

January 12, 1990

Field Studies Chief Leave For Job with Upton; Sibal Named DCCP Acting Deputy

October 27, 1978

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

Cancer Nurses Urged To Take ‘Proactive Stance’ against Budget Cutting

October 16, 1987

NCI, EORTC Offer Support For Russian Cancer Researchers

April 14, 1995

NCAB Asks Government To Take Steps Aimed at Reducing Health Hazards From Cigarettes

December 21, 1973